Denmark· DK-28101818896
Myambutol
A ethambutol product containing ethambutolhydrochlorid, registered in Denmark by Orifarm A/S. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Ethambutol is registered in 15 of 19 countries.
Countries holding a registration under ATC J04AK02 (ethambutol), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Ethambutol · ATC J04AK02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ethambutol costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), the median price runs from $0.24 in France to $4.44 in Switzerland — a ×18 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ethambutol · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.44
- FR France$0.24
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Ethambutolhydrochlorid
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- J04AK02
- ATC class
- Ethambutol
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101818896
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
148 interactions on record for ethambutol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ethambutol · interactions on record
148 records
- 4 severe
- 78 moderate
- 65 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J04AK02
Ethambutol, as other registers publish it.
- FranceDEXAMBUTOL 500 mg, comprimé pelliculéSERP
- GermanyEmb-FatolEsteve Pharmaceuticals Gmbh
- GermanyEmb-FatolEsteve Pharmaceuticals Gmbh
- NorwayEMB-FatolRiemser Pharma GmbH
- NorwayEMB-FatolEsteve
- United KingdomEMB-Fatol 1g/10ml concentrate for solution for infusion vialsImported (Germany)
- CzechiaETAMBUTOL ATB
- FinlandEtbutolSchering Oy
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4ba49848-492e-4c98-b89f-b8efc9113b2c GET /v1/drugs/4ba49848-492e-4c98-b89f-b8efc9113b2c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter",
"source": "dkma",
"strength": "400 mg",
"auth_role": "DKMA",
"dk_drugid": "28101818896",
"substance": "Ethambutolhydrochlorid",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "35389"
}See everything about ethambutol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.